Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: Evaluation using home-based blood pressure measurements

Journal of Hypertension

Volumn 21, Issue 4, 2003, Pages 805-811

  Hashimoto, Junichiro ^a   Chonan, Kenichi ^a   Aoki, Yohei ^a   Ugajin, Takashi ^a   Yamaguchi, Junko ^a   Nishimura, Takuya ^a   Kikuya, Masahiro ^a   Michimata, Mari ^a   Matsubara, Mitsunobu ^a   Araki, Tsutomu ^a   Hozawa, Atsushi ^a   Ohkubo, Takayoshi ^a   Imai, Yutaka ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Clonidine; Guanabenz; Home blood pressure; Hypertension

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GUANABENZ;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CONFERENCE PAPER; DRUG EFFECT; FEMALE; HOME CARE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0038708273     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200304000-00025     Document Type: Conference Paper

References (39)

1. Muller JE. Circadian variation in cardiovascular events. Am J Hypertens 1999; 12:35S-42S.
2. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:1315-1322.
3. Willich SN, Linderer T, Wegsheider K, Leizorovicz A, Alamercery I, Schroder R. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior beta-adrenergic blockade. Circulation 1989; 80:853-858.
4. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75:395-400.
5. Mulcahy D, Keegan J, Cunningham D, Quyyumi A, Crean P, Park A, et al. Circadian variation of total ischemic burden and its alteration with anti-anginal agents. Lancet 1988; 2:755-759.
6. Goldberg RJ, Brady P, Muller JE, Chen Z, De Groot M, Zonneveld P, et al. Time of onset of symptoms of acute myocardial infarction. Am J Cardiol 1990; 66:140-144.
7. Elliot WJ. Circadian variation in the time of stroke onset. Stroke 1998; 29:992-996.
8. Soo LH, Gray D, Young T, Hampton JR. Circadian variation in witnessed out of hospital cardiac arrest. Heart 2000; 84:370-376.
9. Manfredini R, Portaluppi F, Zamboni P, Salmi R, Gallerani M. Circadian variation in spontaneous rupture of abdominal aorta. Lancet 1999; 353:643-644.
10. Redón J, Bertolin V, Giner V, Lurbe E. Assessment of blood pressure early morning rise. Blood Press Monit 2001; 6:207-210.
11. Dodt C, Breckling U, Derad I, Fehm HL, Born J. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997; 30:71-76.
12. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316:1514-1518.
13. Andreotti F, Davies GJ, Hackett DR, Khan MI, De Bart ACW, Aber VR, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, SCD, and stroke. Am J Cardiol 1988; 62:635-637.
14. White WB. Cardiovascular risk and the therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit 2001; 6:63-72.
15. Hashimoto J, Imai Y, Minami N, Munakata M, Sakuma H, Sasaki S, et al. A high-salt diet alters circadian rhythm in Dahl rats. Tohoku J Exp Med 1994; 173:345-354.
16. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to α-sympathetic vasoconstrictor activity. N Engl J Med 1991; 325:986-990.
17. Chonan K, Hashimoto J, Ohkubo T, Tsuji I, Nagai K, Kikuya M, et al. Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: the Ohasama study. Clin Exp Hypertens 2002; 24:261-275.
18. Pickering TG, Levenstein M, Walmsley P. Nighttime dosing of doxazosin has peak effect of morning ambulatory blood pressure. Results of the HALT study. Am J Hypertens 1994; 7:844-847.
19. DeQuattro V, Lee DD-P, Allen J, Sirgo M, Plachetka J. Labetalol blunts morning pressor surge in systolic hypertension. Hypertension 1988; 11 (suppl I):1198-1201.
20. Van Zweiten PA. The renaissance of centrally acting antihypertensive drugs. J Hypertens 1999; 17 (suppl 3):S15-S21.
21. 2-agonist, suppresses morning elevation in aggregation of human platelets. J Cardiovasc Pharmacol 2001; 37:89-93.
22. Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, et al. Usefulness of home blood pressure measurement in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens 2001; 19:179-185.
23. Pickering TG, for an American Society of Hypertension Ad Hoc Panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1995; 9:1-11.
24. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
25. Menard J, Chatellier G, Day M, Vaur L. Self-measurement of blood pressure at home to evaluate drug effects by the trough:peak ratio. J Hypertens 1994; 12 (suppl 8):S21-S25.
26. Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Chatellier G, Elkik F, et al. Assessment of drug efficacy using home self-blood pressure measurement: the SMART study. J Hum Hypertens 1996; 10:341-347.
27. Fenichel RR, Lipicki RJ. On the trough:peak ratio of drug effect in antihypertensive trials. Am J Hypertens 1996; 9:105S-107S.
28. Stergiou GS, Skeva II, Zourbaki AS, Mountokalakis TD. Self-monitoring of blood pressure at home: how many measurements are needed? J Hypertens 1998; 16:725-723.
29. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 1993; 125:1148-1154.
30. Umeda T, Naomi S, Iwaoka T, Inoue J, Sasaki M, Ideguchi Y, et al. Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension 1994; 23 (suppl I):1211-1214.
31. Jain AK, Ryan JR, Vargas R, McMahon FG. Efficacy and acceptability of different dosage schedules of clonidine. Clin Pharmacol Ther 1977; 21:382-387.
32. Oster JR, Epstein M. Use of centrally acting sympatholytic agents in the management of hypertension. Arch Intern Med 1991; 151:1638-1644.
33. Walker BR, Hare LE, Deitch MW. Comparative antihypertensive effects of guanabenz and clonidine. J Int Med Res 1982; 10:6-14.
34. Lipicky RJ. Trough/peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994; 12 (suppl 8):S17-S18.
35. Palatini P. Importance of various methods of blood pressure measurement in clinical trials. Curr Hypertens Rep 2000; 2:362-369.
36. Davis DS, Wing LMH, Reid JL, Neill E, Tippett P, Dollery CT. Pharmacokinetics and concentration - effect relationships of intravenous and oral clonidine. Clin Pharmacol Ther 1977; 21:593-601.
37. 14C-guanabenz in patients with essential hypertension. Clin Pharmacol Ther 1980; 27:44-52.
38. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of α-adrenergic blocker, doxazosin. Results from the HALT study. Hypertension 2000; 35:787-794.
39. Ouchi Y, Nakamura T, Terashita K, Nakamura Y, Aiso Y, Shirai T, et al. Effect of guanabenz on diurnal ambulatory blood-pressure variation in mild to moderate hypertension. Cardiovasc Rev Rep 1992; 13:42-49.